Northwestern Mutual Investment Management Company, LLC Biomarin Pharmaceutical Inc Transaction History
Northwestern Mutual Investment Management Company, LLC
- $4.26 Billion
- Q3 2024
A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 42,238 shares of BMRN stock, worth $2.68 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
42,238
Previous 42,379
0.33%
Holding current value
$2.68 Million
Previous $3.49 Million
14.93%
% of portfolio
0.07%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
635Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.2 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$881 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$666 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...